Ontario Institute for Cancer Research
Projects
-
Orthogonal pangenome sequencing to unveil genetic cancer susceptibility diagnostic odysseys: a Return of Results Working Group new technology assessment study
Using long-read sequencing to reveal unknown hereditary links to cancer -
Plasma whole genome sequencing in pancreatic and biliary cancers
Advancing plasma whole genome sequencing to better treat and monitor patients with pancreatic and biliary cancers
Related News
-
Marathon of Hope Cancer Centres Network operational plan continues to take shape
Stakeholders from partner institutions across Canada are meeting on a regular basis to operationalize the Marathon of Hope Cancer Centres Network. -
MOHCCN Pathfinder Project clears the way for future data sharing between Network members
Through its Pathfinder Project, the MOHCCN has developed and deployed a technical tool that allows members to upload, discover – and eventually access – the data needed to accelerate precision medicin... -
Network names 10 early-career data scientists as recipients of its 2024 Health Informatics & Data Science Awards
Each will receive $40,000 from the Network over the next year to be matched by their host institutions for a total of $80,000 to support groundbreaking research in precision oncology. -
Meet the Team Canada of Cancer Research: A Q&A with Dr. Lincoln Stein
We spoke to Dr. Stein to learn more about his career, his research and how initiatives like the Marathon of Hope Cancer Centres Network (MOHCCN) are driving collaboration across Canada for the benefit... -
New study shows how comprehensive sequencing and molecular tumour boards can help put precision oncology into practice
Precision oncology is a promising approach for personalized cancer treatments. A new study from a Network-funded team demonstrates how it can be put into practice, and the challenges that remain to ma... -
Health technology assessment innovators share their research with the Network
On Thursday, January 15, MOHCCN members conducting Network-funded projects in the health technology assessment space presented their ongoing work in precision oncology to Network members as part of th... -
Precision medicine should be first-line treatment for metastatic pancreatic cancer, study finds
A new clinical trial comparing the efficacy of two treatments commonly used on patients with metastatic pancreatic cancer has shed new light on the importance of using genomic sequencing to inform car...
-
Regional Consortia
Ontario Cancer Consortium
The Ontario Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine for cance...Read more
-
